Skip to content

The Effect of Continuous Epidural Analgesia on Intracranial Pressure by Measuring the Optic Nerve Sheath Diameter Using Ultrasound in Pediatric Patients

The Effect of Continuous Epidural Analgesia on Intracranial Pressure by Measuring the Optic Nerve Sheath Diameter Using Ultrasound in Pediatric Patients

Status
UNKNOWN
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT03911804
Enrollment
60
Registered
2019-04-11
Start date
2019-04-30
Completion date
2021-03-31
Last updated
2019-04-11

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Osteotomy of Lower Extremity

Brief summary

Ultrasonography of optic nerve sheath diameter shows a good level of diagnostic accuracy for detecting intracranial hypertension. The aim of this study is to evaluate the effect of continuous epidural block on intracranial pressure in pediatric patients undergoing osteotomy of lower extremity. Forty patients, aged 4 years to 13 years, receiving epidural analgesia before osteotomy will be divided into bolus group (n=30) and infusion group (n=30). Randomly selected patients of the bolus group are given 0.3 ml/kg bolus/hr of 0.15% ropivacaine for epidural analgesia. In contrast, patients in the infusion group are administered 0.3 ml/kg/hr 0.15% ropivacaine at a constant rate for epidural analgesia. The primary endpoint is the difference in the optic nerve sheath diameter after epidural analgesia measured by optic nerve ultrasonography between groups.

Interventions

PROCEDUREbolus group and infusion group for epidural block

Randomly selected patients of the bolus group are given 0.3 ml/kg bolus/hr of 0.15% ropivacaine for epidural analgesia. In contrast, patients in the infusion group are administered 0.3 ml/kg/hr 0.15% ropivacaine at a constant rate for epidural analgesia.

Sponsors

Yonsei University
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
TRIPLE (Subject, Caregiver, Investigator)

Masking description

Participants, care providers and investigators are blinded to group assignment.

Intervention model description

Randomly selected patients of the bolus group are given 0.3 ml/kg bolus/hr of 0.15% ropivacaine for epidural analgesia. In contrast, patients in the infusion group are given 0.3 ml/kg/hr 0.15% ropivacaine at a constant rate for epidural analgesia.

Eligibility

Sex/Gender
ALL
Age
4 Years to 13 Years
Healthy volunteers
No

Inclusion criteria

* 1\. Pediatric patients from 4 to 13 years of age undergoing osteotomy of lower extremity

Exclusion criteria

* 1\. Patients with contraindications to epidural analgesia (local infection, clotting disorders, anatomical abnormalities, sepsis, etc.) * 2\. Patients with symptoms or signs associated with a history of elevated intracranial pressure or elevated intracranial pressure * 3\. Patients with ophthalmic disease or surgery * 4\. The estimated operation time is less than 180 minutes. * 5\. All parents of the subject are foreigners or illiterate

Design outcomes

Primary

MeasureTime frameDescription
The difference in the optic nerve sheath diameter (ONSD) between groupsBefore epidural blockThe optic nerve sheath diameter measured by optic nerve ultrasonography

Secondary

MeasureTime frameDescription
The difference in the number of patients whose ONSD values increased to more than 5.75 mm at each time point between the two groupsBefore epidural blockThe optic nerve sheath diameter measured by optic nerve ultrasonography

Countries

South Korea

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026